Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.

Abstract

BACKGROUND Severe side effects during venom immunotherapy (VIT) are associated with a variety of risk factors. OBJECTIVE Our aim was to evaluate the association of baseline serum tryptase concentration (BTC) and of other parameters, which are routinely recorded during patient evaluation, with the frequency of severe reactions requiring an emergency intervention during the buildup phase of VIT. METHODS In this observational prospective multicenter study, we enrolled 680 patients with established honeybee or vespid venom allergy who underwent VIT. Data were collected on tryptase concentration, age, sex, culprit insect, cardiovascular medication, degree of preceding sting reaction, preventive antiallergic medication before therapy, time between last preceding sting reaction and VIT, venom specific IgE concentration, and type of buildup procedure. Relative rates were calculated with generalized additive models. RESULTS Fifty-seven patients (8.4%) required an emergency intervention during buildup because of a severe systemic reaction. The frequency of interventions increased significantly with higher BTC (log-linear association; adjusted odds ratio, 1.56; 95% CI, 1.15-2.11; P < .005). The predictive power of BTC was markedly greater when VIT was performed for vespid venom allergy than for bee venom (for bee VIT, no significant association; for vespid VIT, log-linear association; adjusted odds ratio, 2.33; 95% CI, 1.28-4.26; P = .005). The most important other factor significantly associated with severe reactions during the buildup phase of VIT was bee venom allergy. CONCLUSION Before vespid VIT, measurement of baseline serum tryptase concentration should be used to identify patients with a high risk for side effects. Patients with bee venom allergy require a particularly high degree of surveillance during VIT.

DOI: 10.1016/j.jaci.2010.04.025
0204020102011201220132014201520162017
Citations per Year

127 Citations

Semantic Scholar estimates that this publication has 127 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Ruff2010PredictorsOS, title={Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.}, author={F Ru{\"{e}ff and Bernhard Przybilla and Maria Beatrice Bil{\'o} and Ulrich Mueller and Fabian Scheipl and Werner Aberer and Jo{\"{e}lle Birnbaum and Anna Bodzenta-Lukaszyk and Floriano Bonifazi and Christoph Bucher and Paolo Campi and Ulf Darsow and Cornelia Egger and Gabrielle Haeberli and Thomas Hawranek and Iwona Kucharewicz and Helmut K{\"{u}chenhoff and Roland Lang and Oliviero Quercia and Norbert Reider and Maurizio Giuseppe Severino and M Sticherling and Gunter Johannes Sturm and B. W{\"{u}thrich}, journal={The Journal of allergy and clinical immunology}, year={2010}, volume={126 1}, pages={105-11.e5} }